Rapid influenza diagnostic tests (RIDTs) are type of immunoassays which identifies the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens. The RIDTs have received attention as it offers advantages over the other methods, for instance rapid result in less than approximately 15 minutes, high specificity and easy performance. According to Centers for Disease Control and Prevention 2017 estimation, every year approximately 291,000 and 646,000 people die from seasonal influenza-related respiratory illness globally.
Global rapid influenza diagnostics market is expected to rise with a substantial CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the rising number of geriatric population.
For More Information: @
Market Drivers and Restraints:
Rising government initiatives is expected to drive the growth of the market
Enhancing geriatric population also acts as a major driver for this market growth
Advanced technological diagnostic tests is also augmenting the market growth
High prices of reagents and kits hampers the market growth
Negative results of RIDTs for a tubeless insulin pump also acts as a restricting factor for this market growth
Inconsistency in sensitivity and specificity of diagnostic tests; restricts the growth of the market
The major players covered in the Rapid Influenza Diagnostics Market Forecasted
Few of the major competitors currently working in the global rapid influenza diagnostics market are Abbott, BD, Quidel Corporation., Princeton BioMeditech Corporation, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, DiaSorin S.p.A., SA Scientific, Meridian Bioscience, Inc., Analytik Jena AG (Endress+Hauser Management AG), Luminex Corporation, Boryung Co.,Ltd. among others.
Major TOC Of The Report
Chapter One: Rapid Influenza Diagnostics Market Forecasted Overview
Chapter Two: Manufacturers Profiles
Chapter Three: Global Rapid Influenza Diagnostics Market Forecasted Competition, by Players
Chapter Four: Global Rapid Influenza Diagnostics Market Forecasted Size by Regions
Chapter Five: North America Rapid Influenza Diagnostics Market Forecasted Revenue by Countries
Chapter Six: Europe Rapid Influenza Diagnostics Market Forecasted Revenue by Countries
Chapter Seven: Asia-Pacific Rapid Influenza Diagnostics Market Forecasted Revenue by Countries
Chapter Eight: South America Rapid Influenza Diagnostics Market Forecasted Revenue by Countries
Brief Rapid Influenza Diagnostics Market Report with TOC@
https://www.databridgemarketresearch.com/toc/?dbmr=global-rapid-influenza-diagnostics-market
Key Report Highlights
Comprehensive pricing analysis based on different product types and regional segments
Market size data in terms of revenue and sales volume
Deep insights about regulatory and investment scenarios of the global Rapid Influenza Diagnostics Market Forecasted
Analysis of market effect factors and their impact on the forecast and outlook of the global Rapid Influenza Diagnostics Market Forecasted
The detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the global Rapid Influenza Diagnostics Market Forecasted
A roadmap of growth opportunities available in the global Rapid Influenza Diagnostics Market Forecasted with the identification of key factors
The exhaustive analysis of various trends of the global Rapid Influenza Diagnostics Market Forecasted to help identify market developments
Key Questions Answered in Report:
What is the key to the Rapid Influenza Diagnostics Market Forecasted ?
What will the Rapid Influenza Diagnostics Market Forecasted Demand and what will be Growth?
What are the latest opportunities for Rapid Influenza Diagnostics Market Forecasted in the future?
What are the strengths of the key players?
For Full Report : @
https://www.databridgemarketresearch.com/reports/global-rapid-influenza-diagnostics-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Browse Related Reports@
Rapid influenza diagnostic market tests (RIDTs) are type of immunoassays which identifies the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens.
The RIDTs have received attention as it offers advantages over the other methods, for instance rapid result in less than approximately 15 minutes, high specificity and easy performance.
According to Centers for Disease Control and Prevention 2017 estimation, every year approximately 291,000 and 646,000 people die from seasonal influenza-related respiratory illness globally.Rapid influenza diagnostics market is expected to rise with a substantial CAGR in the forecast period of 2019-2026.
This rise in market value can be attributed to the rising number of geriatric population.This Rapid influenza diagnostics market report studies and analyses facts and figures about the market segmentation very carefully and represent it in the form of graphs for the better understanding of end user.
It not only identifies the emerging trends along with major drivers, challenges and opportunities in the market but also analyses them efficiently.
The market report has been specially designed by keeping in mind the customer requirements with which businesses can get assistance in increasing their return on investment (ROI).
Rapid Influenza Diagnostics Market are type of immunoassays which identifies the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens.
The RIDTs have received attention as it offers advantages over the other methods, for instance rapid result in less than approximately 15 minutes, high specificity and easy performance.
According to Centers for Disease Control and Prevention 2017 estimation, every year approximately 291,000 and 646,000 people die from seasonal influenza-related respiratory illness globally.Global rapid influenza diagnostics market is expected to rise with a substantial CAGR in the forecast period of 2019-2026.
Get Sample Report at : https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-rapid-influenza-diagnostics-marketCompetitive Analysis: Global Rapid Influenza Diagnostics MarketFew of the major competitors currently working in the global rapid influenza diagnostics market are Abbott, BD, Quidel Corporation., Princeton BioMeditech Corporation, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, DiaSorin S.p.A., SA Scientific, Meridian Bioscience, Inc., Analytik Jena AG (Endress+Hauser Management AG), Luminex Corporation, Boryung Co.,Ltd.
Key Pointers Covered in the Global Rapid Influenza Diagnostics Market Trends and Forecast to 2026Global Rapid Influenza Diagnostics Market New Sales VolumesGlobal Rapid Influenza Diagnostics Market Replacement Sales VolumesGlobal Rapid Influenza Diagnostics Market Installed BaseGlobal Rapid Influenza Diagnostics Market By BrandsGlobal Rapid Influenza Diagnostics Market SizeGlobal Rapid Influenza Diagnostics Market Procedure VolumesGlobal Rapid Influenza Diagnostics Market Product Price AnalysisGlobal Rapid Influenza Diagnostics Market Healthcare OutcomesGlobal Rapid Influenza Diagnostics Market Cost of Care AnalysisGlobal Rapid Influenza Diagnostics Market Regulatory Framework and ChangesGlobal Rapid Influenza Diagnostics Market Prices and Reimbursement AnalysisGlobal Rapid Influenza Diagnostics Market Shares in Different RegionsRecent Developments for Global Rapid Influenza Diagnostics Market CompetitorsGlobal Rapid Influenza Diagnostics Market Upcoming ApplicationsGlobal Rapid Influenza Diagnostics Market Innovators StudyGet Detailed TOC:https://www.databridgemarketresearch.com/toc/?dbmr=global-rapid-influenza-diagnostics-market Key Developments in the Market:In February 2019, Abbott launched BinaxNOW Influenza A & B Card 2, a rapid influenza diagnostic test (RIDT).
This reformulated test already received waived status from Clinical Laboratory Improvements Amendments (CLIA) by the U.S. Food and Drug Administration (FDA) for use with Abbott's DIGIVAL diagnostic reader which is specifically designed for the rapid detection of influenza virus.
